A Randomized Trial of Daily and Thrice‐Weekly Trimethoprim‐Sulfamethoxazole for the Prevention ofPneumocystis cariniiPneumonia in Human Immunodeficiency Virus‐Infected Persons

Abstract

We enrolled 2,625 human immunodeficiency virus-infected patients into a randomized trial to assess the efficacy and tolerability of daily vs. thrice-